Skip to main content
Clinical Trials/KCT0007462
KCT0007462Recruiting未知

A comparative clinical trial to evaluate the effectiveness and safety of a digital intervention used to improve glycemic control of patients with type 2 diabetes

Soon Chun Hyang University Hospital Seoul0 sites320 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
320

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
19(Year) to o Limit (—)
Sex
All

Inclusion Criteria

  • A person who satisfies all of the selection criteria presented by the target group
  • - Those who are 19 years of age or older and meet the criteria for diagnosing type 2 diabetes
  • - Patients with HbA1c 6.5-9.0% in the last 3 months
  • - A person who has no difficulty in reading and writing Korean
  • - A person who has no difficulty using a mobile application using a smartphone
  • - A person who upon receiving and understanding sufficient explanation of this clinical trial, the written consent to voluntarily decide to participate and comply with the precautions
  • - A person who voluntarily agrees and visits for observation after explaining the clinical trial

Exclusion Criteria

  • A person who has any of the exclusion criteria
  • - A person who has difficulty using surveys and applications without the help of his/her own doctor or guardian
  • - Patients with type 1 diabetes, gestational diabetes, insulin therapy
  • - A person who has diabetes medication changes in 3 months prior to the clinical study period or those with plans to change during the study period
  • - A person against one's will
  • - A person who are in critical or vulnerable mental conditions
  • - A person who has difficulty in listening, writing, and speaking Korean
  • - A person who has difficulty in using general-purpose equipment

Investigators

Sponsor
Soon Chun Hyang University Hospital Seoul

Similar Trials

A comparative clinical trial to evaluate... | Clinical Trial